Literature DB >> 12217689

The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.

Stefan Bäckström1, Magnus Wolf-Watz, Christine Grundström, Torleif Härd, Thomas Grundström, Uwe H Sauer.   

Abstract

The evolutionarily conserved Runt homology domain is characteristic of the RUNX family of heterodimeric eukaryotic transcription factors, including RUNX1, RUNX2 and RUNX3. The genes for RUNX1, also termed acute myeloid leukemia protein 1, AML1, and its dimerization partner core-binding factor beta, CBFbeta, are essential for hematopoietic development and are together the most common targets for gene rearrangements in acute human leukemias. Here, we describe the crystal structure of the uncomplexed RUNX1 Runt domain at 1.25A resolution and compare its conformation to previously published structures in complex with DNA, CBFbeta or both. We find that complex formation induces significant structural rearrangements in this immunoglobulin (Ig)-like DNA-binding domain. Most pronounced is the movement of loop L11, which changes from a closed conformation in the free Runt structure to an open conformation in the CBFbeta-bound and DNA-bound forms. This transition, which we refer to as the S-switch, and accompanying structural movements that affect other parts of the Runt domain are crucial for sustained DNA binding. The closed to open transition can be induced by CBFbeta alone; suggesting that one role of CBFbeta is to trigger the S-switch and to stabilize the Runt domain in a conformation enhanced for DNA binding.A feature of the Runt domain hitherto unobserved in any Ig-like DNA-binding domain is the presence of two specifically bound chloride ions. One chloride ion is coordinated by amino acid residues that make direct DNA contact. In a series of electrophoretic mobility-shift analyses, we demonstrate a chloride ion concentration-dependent stimulation of the DNA-binding activity of Runt in the physiological range. A comparable DNA-binding stimulation was observed for negatively charged amino acid residues. This suggests a regulatory mechanism of RUNX proteins through acidic amino acid residues provided by activation domains during cooperative interaction with other transcription factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217689     DOI: 10.1016/s0022-2836(02)00702-7

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

1.  Statistical analysis of interface similarity in crystals of homologous proteins.

Authors:  Qifang Xu; Adrian A Canutescu; Guoli Wang; Maxim Shapovalov; Zoran Obradovic; Roland L Dunbrack
Journal:  J Mol Biol       Date:  2008-06-07       Impact factor: 5.469

2.  The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation.

Authors:  Wei Zhu; Xinyu He; Yue Hua; Qian Li; Jiyong Wang; Xiaoqing Gan
Journal:  J Biol Chem       Date:  2017-05-12       Impact factor: 5.157

3.  Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.

Authors:  Teddy T C Yang; Qiufang Xiong; Isabella A Graef; Gerald R Crabtree; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation.

Authors:  Zhe Li; Steven M Lukasik; Yizhou Liu; Jolanta Grembecka; Izabela Bielnicka; John H Bushweller; Nancy A Speck
Journal:  J Mol Biol       Date:  2006-10-04       Impact factor: 5.469

5.  Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia.

Authors:  Cinzia Puppin; Lucia Pellizzari; Dora Fabbro; Federico Fogolari; Gianluca Tell; Alessanda Tessa; Filippo M Santorelli; Giuseppe Damante
Journal:  J Hum Genet       Date:  2005-10-22       Impact factor: 3.172

6.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

7.  Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA.

Authors:  Sanjeev K Baniwal; Omar Khalid; Donna Sir; Grant Buchanan; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Endocrinol       Date:  2009-04-23

Review 8.  FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity.

Authors:  Zhaocai Zhou; Xiaomin Song; Bin Li; Mark I Greene
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element.

Authors:  Junichi Fukunaga; Yusuke Nomura; Yoichiro Tanaka; Ryo Amano; Taku Tanaka; Yoshikazu Nakamura; Gota Kawai; Taiichi Sakamoto; Tomoko Kozu
Journal:  RNA       Date:  2013-05-24       Impact factor: 4.942

10.  The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms.

Authors:  Jessica Rennert; James A Coffman; Arcady R Mushegian; Anthony J Robertson
Journal:  BMC Evol Biol       Date:  2003-03-24       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.